Autologous blood boosts vein graft viability in coronary bypass surgery

Researchers have unveiled a game-changing technique for preserving veins during coronary bypass grafts.

New findings suggest that substituting the traditional saline solution with a mixture of the anticoagulant heparin and a patient’s own blood significantly enhances the protection of veins from cell and tissue damage.

The study was conducted by the Fralin Biomedical Research Institute at VTC and Carilion Clinic and published in the January issue of the Journal of Vascular Research.

Nullam et interdum sapien, eu facilisis erat. Etiam eget quam nisi. Integer imperdiet eros vel lorem pellentesque, non ornare libero aliquam. Phasellus nec urna molestie, pellentesque nisi at, volutpat odio. Mauris pulvinar efficitur neque at pretium. Nunc euismod turpis ante, et porttitor diam auctor sed. Ut erat metus, tincidunt a malesuada nec, blandit ut felis. Nullam pulvinar ac dolor at euismod. Curabitur scelerisque ac urna in cursus. Nulla nisi elit, consectetur a sem ac, laoreet condimentum massa
Register for free or to unlock this article
To gain full access to the only resource for industry news, simply register for free.
Already registered?
Connecting Surgeons.
Shaping the future.
connecting surgeons. shaping the future
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram